SecBot SecBot
PRESS-RELEASE ·Filed May 6, 2026

MNKD

MannKind
BEARISH
Impact 8/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The significant earnings miss likely pressures MNKD near term, but upcoming PDUFA catalysts (Afrezza pediatric, Furoscix ReadyFlow) may limit downside. Traders should monitor for any pre-approval signals and upcoming Phase 2 data for nintedanib DPI.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.55
T+0 close · May 6, 2026 · via day close
Latest settled
+7.04%
T+60 · $3.80
Vs SPY
+3.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $3.55entry
  2. T+1 · 6mo ago 0.00%α −0.83% · $3.55
  3. T+5 · 6mo ago −9.58%α −11.08% · $3.21
  4. T+20 · 6mo ago −5.35%α −8.49% · $3.36
  5. T+60 · 4mo ago +7.04%α +3.21% · $3.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MannKind reported Q1 2026 GAAP EPS of -$0.05, a 600% miss vs. consensus of $0.01, and revenue of $90.2M, 14.4% below the $105.3M estimate. The miss was driven by a 116% surge in SG&A from Furoscix expansion and R&D ramp-up, despite a 15% YoY revenue increase. Pipeline catalysts (Afrezza pediatric PDUFA May 29, Furoscix ReadyFlow PDUFA July 26) provide optionality but do not offset the earnings disappointment.

Key Financial Metrics

EPS
−$0.05
est $0.01 · -600.0%
Revenue
$90.2M
est $105.3M · -14.4% · +15.0% YoY
Rating
strong miss
Gross Margin
80.6%

Key Facts

  • GAAP EPS -$0.05 vs. consensus $0.01 (-600% miss)
  • Revenue $90.2M vs. consensus $105.3M (-14.4% miss)
  • YoY revenue growth 15% ($78.4M to $90.2M)
  • SG&A expenses increased 116% to $54.1M
  • Net loss $16.6M vs. net income $13.2M in Q1 2025
  • Cash and investments $134M at quarter end
  • Key upcoming PDUFA dates: Afrezza pediatric May 29, Furoscix ReadyFlow July 26

Financial Impact

Q1 EPS miss of $0.06 per share and revenue miss of $15.1M

epsrevenueoperating expensesnet income

Risk Factors

  • Failed regulatory approvals for Afrezza pediatric or Furoscix ReadyFlow
  • Continued elevated operating expenses without commensurate revenue growth
  • Potential further dilution from debt settlements

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3289304

Track record

17 reports on MNKD

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.00% at T+60 after the May 27, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $4.23 Now $3.96 −6.38% settles Dec 9
  2. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  3. Nov 5, 202611d ago Press Release Bearish 5/10 Entry $3.90 Now $3.96 −1.54% settles Dec 7
  4. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $3.73 Now $3.96 +6.17% settles Dec 2
  5. Jul 29, 202615w ago Press Release Bullish 6/10 Entry $3.85 to $4.09 Now $3.96 +2.86% ▲ +6.23% +1.21% vs SPY
  6. Jul 24, 202616w ago 8-K Mixed 6/10 Entry $3.95 to $4.07 Now $3.96 +0.25% ▲ +3.04% −0.26% vs SPY
  7. Jul 17, 202617w ago Insider Cluster Neutral 3/10 Entry $3.98 to $3.90 Now $3.96 −0.50% ▼ −2.01% −6.13% vs SPY
  8. Jun 3, 202623w ago Press Release Neutral 5/10 Entry $3.36 to $4.52 Now $3.96 +17.86% ▲ +34.52% +35.52% vs SPY
  9. Jun 2, 202623w ago 8-K Bullish 7/10 Entry $3.43 to $4.05 Now $3.96 +15.45% ▲ +18.08% +19.64% vs SPY
  10. May 29, 202624w ago Press Release Bullish 8/10 Entry $3.77 to $4.24 Now $3.96 +5.04% ▲ +12.47% +14.26% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (11h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026